Preventive chemotherapy of tuberculosis in Cornell model mice with combinations of rifampin, isoniazid, and pyrazinamide.
about
Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Joint Tuberculosis Committee of the British Thoracic SocietyFoamy macrophages and the progression of the human tuberculosis granulomaMetronidazole therapy in mice infected with tuberculosisAnalysis of rifapentine for preventive therapy in the Cornell mouse model of latent tuberculosisActivities of rifampin, Rifapentine and clarithromycin alone and in combination against mycobacterium ulcerans disease in miceSuccessful shortening of tuberculosis treatment using adjuvant host-directed therapy with FDA-approved phosphodiesterase inhibitors in the mouse modelBactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosis.Sterilizing activity of thioridazine in combination with the first-line regimen against acute murine tuberculosis.Revisiting Anti-tuberculosis Activity of Pyrazinamide in Mice.Comparative studies evaluating mouse models used for efficacy testing of experimental drugs against Mycobacterium tuberculosis.Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis.Characterization of mouse models of Mycobacterium avium complex infection and evaluation of drug combinations.Synergistic activity of R207910 combined with pyrazinamide against murine tuberculosisModeling early bactericidal activity in murine tuberculosis provides insights into the activity of isoniazid and pyrazinamideEnhanced bactericidal activity of rifampin and/or pyrazinamide when combined with PA-824 in a murine model of tuberculosis.Adjuvant host-directed therapy with types 3 and 5 but not type 4 phosphodiesterase inhibitors shortens the duration of tuberculosis treatmentPotent rifamycin-sparing regimen cures guinea pig tuberculosis as rapidly as the standard regimenInvestigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse ModelPromising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine modelStatin adjunctive therapy shortens the duration of TB treatment in mice.Acceleration of tuberculosis treatment by adjunctive therapy with verapamil as an efflux inhibitorParadoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosis.Short-course therapy with daily rifapentine in a murine model of latent tuberculosis infection.Assessment of the Efficacy of New Anti-Tuberculosis Drugs.New 2-thiopyridines as potential candidates for killing both actively growing and dormant Mycobacterium tuberculosis cells.Metformin Adjunctive Therapy Does Not Improve the Sterilizing Activity of the First-Line Antitubercular Regimen in Mice.Impact of Clofazimine Dosing on Treatment-Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis.
P2860
Q24679389-566AA001-0CDC-46A3-96D0-7B34AA8F179CQ28255669-137CC497-D905-42D3-9208-1B436DFCF509Q28343302-8FE67B3D-F0BA-499A-BFF4-1CAEB002419AQ28343546-5C4A8D6E-5D38-489B-B65F-D63400036BD1Q28476689-AB055105-A755-4883-83C6-9963447BA331Q28480511-3942ADCC-32F4-49B8-A892-A954B5DC08C7Q33836692-5D6641AB-FAF4-46B0-A58C-30E3DF9F6C1AQ34057500-52322B30-DD66-4E4E-B6E4-4D1904D2A302Q34708437-8C0DC581-6D13-485A-BC1D-BAEA12AC736AQ34737143-9DB07B43-4228-40C8-A075-73E17F5DFAE8Q34973845-AFB230D7-3A54-4534-82E5-C1F37F2D7CC3Q35169086-C07EC0B7-8CE6-4AA7-BEC3-9EFAAC75CD07Q35647811-E3AE4B69-2F6C-4DDB-87DC-42F03BE95905Q36236341-2CEF7275-34BC-4618-9C63-A05422E0DCB2Q36932905-4A82B1F2-5D0B-4A74-A74E-EBD468F4B3D5Q36974934-CDC3765B-3C27-40C1-AA5B-14E695E8D7CEQ37036499-A6C6C5B0-3C7E-4341-AA80-1A06FF25CAD0Q37119985-4379C009-558A-42A2-AF3E-FB718785E587Q37144892-27B63F53-DE36-4D45-8763-5354946E5D57Q37223747-05E535B4-E5B1-49B3-9B18-AF52ABCDF497Q37307531-2FD020E2-A9E9-40F5-BC9D-240D660D4D06Q37392767-805A78CB-50BB-4A74-9CFD-1849E57EE79CQ37443290-0641F643-31B9-4059-91E0-35197ABD0664Q41572870-3C57C98B-717D-41AF-AAC6-2926F34D5B2BQ41907472-43602793-E82F-48B5-ABA7-FD5CE10BDEDEQ48355478-A6E84D71-6F66-46BD-9328-0A7DB74FC5BFQ53686602-3678C7CA-8C97-4CA8-8694-B42CF99674B1
P2860
Preventive chemotherapy of tuberculosis in Cornell model mice with combinations of rifampin, isoniazid, and pyrazinamide.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Preventive chemotherapy of tub ...... , isoniazid, and pyrazinamide.
@en
Preventive chemotherapy of tub ...... , isoniazid, and pyrazinamide.
@nl
type
label
Preventive chemotherapy of tub ...... , isoniazid, and pyrazinamide.
@en
Preventive chemotherapy of tub ...... , isoniazid, and pyrazinamide.
@nl
prefLabel
Preventive chemotherapy of tub ...... , isoniazid, and pyrazinamide.
@en
Preventive chemotherapy of tub ...... , isoniazid, and pyrazinamide.
@nl
P2093
P2860
P1476
Preventive chemotherapy of tub ...... , isoniazid, and pyrazinamide.
@en
P2093
Dickinson JM
Mitchison DA
P2860
P304
P407
P577
1996-03-01T00:00:00Z